Loading...

Jacqueline Crawley

Title(s)Professor, Psychiatry and Behavioral Sciences
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Convergent Synaptic Mechanisms in Neurodevelopmental Disorders
    NIH/NINDS R01NS085709Sep 1, 2013 - May 31, 2018
    Role: Principal Investigator
    Behavioral Functions of Neuropeptides
    NIH/NIMH Z01MH002177
    Role: Principal Investigator
    Animal Models Of Neuropsychiatric Disorders
    NIH/NIMH Z01MH002179
    Role: Principal Investigator
    Animal Models Of Neuropsychiatric Disorders
    NIH/NIMH ZIAMH002179
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Dutta R, Crawley JN. Behavioral Evaluation of Angelman Syndrome Mice at Older Ages. Neuroscience. 2019 Nov 12. PMID: 31730795.
      View in: PubMed
    2. Crawley JN, Fagiolini M, Harrison FE, Samaco R, Wozniak DF, Robinson MB. Behavioral analyses of animal models of intellectual and developmental disabilities. Neurobiol Learn Mem. 2019 Nov; 165:107087. PMID: 31499164.
      View in: PubMed
    3. Le Duc D, Giulivi C, Hiatt SM, Napoli E, Panoutsopoulos A, Harlan De Crescenzo A, Kotzaeridou U, Syrbe S, Anagnostou E, Azage M, Bend R, Begtrup A, Brown NJ, Büttner B, Cho MT, Cooper GM, Doering JH, Dubourg C, Everman DB, Hildebrand MS, Santos FJR, Kellam B, Keller-Ramey J, Lemke JR, Liu S, Niyazov D, Payne K, Person R, Quélin C, Schnur RE, Smith BT, Strober J, Walker S, Wallis M, Walsh L, Yang S, Yuen RKC, Ziegler A, Sticht H, Pride MC, Orosco L, Martínez-Cerdeño V, Silverman JL, Crawley JN, Scherer SW, Zarbalis KS, Jamra R. Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size. Brain. 2019 Sep 01; 142(9):2617-2630. PMID: 31327001.
      View in: PubMed
    4. Lauterborn JC, Schultz MN, Le AA, Amani M, Friedman AE, Leach PT, Gall CM, Lynch GS, Crawley JN. Spaced training improves learning in Ts65Dn and Ube3a mouse models of intellectual disabilities. Transl Psychiatry. 2019 06 10; 9(1):166. PMID: 31182707.
      View in: PubMed
    5. Buxbaum JD, Baron-Cohen S, Anagnostou E, Ashwin C, Betancur C, Chakrabarti B, Crawley JN, Hoekstra RA, Hof PR, Lai MC, Lombardo MV, Schumann CM. Rigor in science and science reporting: updated guidelines for submissions to Molecular Autism. Mol Autism. 2019; 10:6. PMID: 30828415.
      View in: PubMed
    6. Rhine MA, Parrott JM, Schultz MN, Kazdoba TM, Crawley JN. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism. Autism Res. 2019 Mar; 12(3):401-421. PMID: 30653853.
      View in: PubMed
    7. Vogel Ciernia A, Yasui DH, Pride MC, Durbin-Johnson B, Noronha AB, Chang A, Knotts TA, Rutkowsky JR, Ramsey JJ, Crawley JN, LaSalle JM. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome. Hum Mol Genet. 2018 12 01; 27(23):4077-4093. PMID: 30137367.
      View in: PubMed
    8. Deurloo MHS, Turlova E, Chen WL, Lin YW, Tam E, Tassew NG, Wu M, Huang YC, Crawley JN, Monnier PP, Groffen AJA, Sun HS, Osborne LR, Feng ZP. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models. Mol Neurobiol. 2019 May; 56(5):3313-3325. PMID: 30120731.
      View in: PubMed
    9. Jones KL, Pride MC, Edmiston E, Yang M, Silverman JL, Crawley JN, Van de Water J. Autism-specific maternal autoantibodies produce behavioral abnormalities in an endogenous antigen-driven mouse model of autism. Mol Psychiatry. 2018 Jun 28. PMID: 29955164.
      View in: PubMed
    10. Matt L, Kirk LM, Chenaux G, Speca DJ, Puhger KR, Pride MC, Qneibi M, Haham T, Plambeck KE, Stern-Bach Y, Silverman JL, Crawley JN, Hell JW, Díaz E. SynDIG4/Prrt1 Is Required for Excitatory Synapse Development and Plasticity Underlying Cognitive Function. Cell Rep. 2018 02 27; 22(9):2246-2253. PMID: 29490264.
      View in: PubMed
    11. Leach PT, Crawley JN. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities. Genes Brain Behav. 2018 07; 17(6):e12452. PMID: 29266714.
      View in: PubMed
    12. Gulinello M, Mitchell HA, Chang Q, Timothy O'Brien W, Zhou Z, Abel T, Wang L, Corbin JG, Veeraragavan S, Samaco RC, Andrews NA, Fagiolini M, Cole TB, Burbacher TM, Crawley JN. Rigor and reproducibility in rodent behavioral research. Neurobiol Learn Mem. 2018 Jan 04. PMID: 29307548.
      View in: PubMed
    13. Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018 04; 17(4):280-299. PMID: 29217836.
      View in: PubMed
    14. Stoppel LJ, Kazdoba TM, Schaffler MD, Preza AR, Heynen A, Crawley JN, Bear MF. R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice. Neuropsychopharmacology. 2018 02; 43(3):513-524. PMID: 28984295.
      View in: PubMed
    15. Gompers AL, Su-Feher L, Ellegood J, Copping NA, Riyadh MA, Stradleigh TW, Pride MC, Schaffler MD, Wade AA, Catta-Preta R, Zdilar I, Louis S, Kaushik G, Mannion BJ, Plajzer-Frick I, Afzal V, Visel A, Pennacchio LA, Dickel DE, Lerch JP, Crawley JN, Zarbalis KS, Silverman JL, Nord AS. Germline Chd8 haploinsufficiency alters brain development in mouse. Nat Neurosci. 2017 Aug; 20(8):1062-1073. PMID: 28671691.
      View in: PubMed
    16. Dhamne SC, Silverman JL, Super CE, Lammers SHT, Hameed MQ, Modi ME, Copping NA, Pride MC, Smith DG, Rotenberg A, Crawley JN, Sahin M. Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism. Mol Autism. 2017; 8:26. PMID: 28638591.
      View in: PubMed
    17. Vogel Ciernia A, Pride MC, Durbin-Johnson B, Noronha A, Chang A, Yasui DH, Crawley JN, LaSalle JM. Early motor phenotype detection in a female mouse model of Rett syndrome is improved by cross-fostering. Hum Mol Genet. 2017 05 15; 26(10):1839-1854. PMID: 28334953.
      View in: PubMed
    18. Yan L, Shamir A, Skirzewski M, Leiva-Salcedo E, Kwon OB, Karavanova I, Paredes D, Malkesman O, Bailey KR, Vullhorst D, Crawley JN, Buonanno A. Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders. Mol Psychiatry. 2018 05; 23(5):1233-1243. PMID: 28322273.
      View in: PubMed
    19. Sukoff Rizzo SJ, Crawley JN. Behavioral Phenotyping Assays for Genetic Mouse Models of Neurodevelopmental, Neurodegenerative, and Psychiatric Disorders. Annu Rev Anim Biosci. 2017 02 08; 5:371-389. PMID: 28199172.
      View in: PubMed
    20. Pearson BL, Crawley JN, Eilam D, Pentkowski NS, Summers CH. Curiosity as an approach to ethoexperimental analysis: Behavioral neuroscience as seen by students and colleagues of Bob Blanchard. Neurosci Biobehav Rev. 2017 05; 76(Pt B):415-422. PMID: 27018381.
      View in: PubMed
    21. Leach PT, Hayes J, Pride M, Silverman JL, Crawley JN. Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task. eNeuro. 2016 Jan-Feb; 3(1). PMID: 27022628.
      View in: PubMed
    22. Crawley JN, Heyer WD, LaSalle JM. Autism and Cancer Share Risk Genes, Pathways, and Drug Targets. Trends Genet. 2016 Mar; 32(3):139-146. PMID: 26830258.
      View in: PubMed
    23. Kazdoba TM, Leach PT, Yang M, Silverman JL, Solomon M, Crawley JN. Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics. Curr Top Behav Neurosci. 2016; 28:1-52. PMID: 27305922.
      View in: PubMed
    24. Daimon CM, Jasien JM, Wood WH, Zhang Y, Becker KG, Silverman JL, Crawley JN, Martin B, Maudsley S. Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder. Front Physiol. 2015; 6:324. PMID: 26635614.
      View in: PubMed
    25. Yang M, Lewis FC, Sarvi MS, Foley GM, Crawley JN. 16p11.2 Deletion mice display cognitive deficits in touchscreen learning and novelty recognition tasks. Learn Mem. 2015 Dec; 22(12):622-32. PMID: 26572653.
      View in: PubMed
    26. Kazdoba TM, Hagerman RJ, Zolkowska D, Rogawski MA, Crawley JN. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl). 2016 Jan; 233(2):309-23. PMID: 26525567.
      View in: PubMed
    27. Kazdoba TM, Leach PT, Crawley JN. Behavioral phenotypes of genetic mouse models of autism. Genes Brain Behav. 2016 Jan; 15(1):7-26. PMID: 26403076.
      View in: PubMed
    28. Genestine M, Lin L, Durens M, Yan Y, Jiang Y, Prem S, Bailoor K, Kelly B, Sonsalla PK, Matteson PG, Silverman J, Crawley JN, Millonig JH, DiCicco-Bloom E. Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior. Hum Mol Genet. 2015 Oct 15; 24(20):5805-27. PMID: 26220976.
      View in: PubMed
    29. Ellegood J, Crawley JN. Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism. Neurotherapeutics. 2015 Jul; 12(3):521-33. PMID: 26036957.
      View in: PubMed
    30. Yang M, Lewis F, Foley G, Crawley JN. In tribute to Bob Blanchard: Divergent behavioral phenotypes of 16p11.2 deletion mice reared in same-genotype versus mixed-genotype cages. Physiol Behav. 2015 Jul 01; 146:16-27. PMID: 26066718.
      View in: PubMed
    31. Silverman JL, Pride MC, Hayes JE, Puhger KR, Butler-Struben HM, Baker S, Crawley JN. GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism. Neuropsychopharmacology. 2015 Aug; 40(9):2228-39. PMID: 25754761.
      View in: PubMed
    32. Yang M, Mahrt EJ, Lewis F, Foley G, Portmann T, Dolmetsch RE, Portfors CV, Crawley JN. 16p11.2 Deletion Syndrome Mice Display Sensory and Ultrasonic Vocalization Deficits During Social Interactions. Autism Res. 2015 Oct; 8(5):507-21. PMID: 25663600.
      View in: PubMed
    33. Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Peñagarikano O, Geschwind DH, Pacey LK, Hampson DR, Laliberté CL, Mills AA, Tam E, Osborne LR, Kouser M, Espinosa-Becerra F, Xuan Z, Powell CM, Raznahan A, Robins DM, Nakai N, Nakatani J, Takumi T, van Eede MC, Kerr TM, Muller C, Blakely RD, Veenstra-VanderWeele J, Henkelman RM, Lerch JP. 3D visualization of the regional differences. Mol Psychiatry. 2015 Feb; 20(1):1. PMID: 25648202.
      View in: PubMed
    34. Bales KL, Solomon M, Jacob S, Crawley JN, Silverman JL, Larke RH, Sahagun E, Puhger KR, Pride MC, Mendoza SP. Long-term exposure to intranasal oxytocin in a mouse autism model. Transl Psychiatry. 2014 Nov 11; 4:e480. PMID: 25386957.
      View in: PubMed
    35. Flannery BM, Silverman JL, Bruun DA, Puhger KR, McCoy MR, Hammock BD, Crawley JN, Lein PJ. Behavioral assessment of NIH Swiss mice acutely intoxicated with tetramethylenedisulfotetramine. Neurotoxicol Teratol. 2015 Jan-Feb; 47:36-45. PMID: 25446016.
      View in: PubMed
    36. Kazdoba TM, Leach PT, Silverman JL, Crawley JN. Modeling fragile X syndrome in the Fmr1 knockout mouse. Intractable Rare Dis Res. 2014 Nov; 3(4):118-33. PMID: 25606362.
      View in: PubMed
    37. Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Peñagarikano O, Geschwind DH, Pacey LK, Hampson DR, Laliberté CL, Mills AA, Tam E, Osborne LR, Kouser M, Espinosa-Becerra F, Xuan Z, Powell CM, Raznahan A, Robins DM, Nakai N, Nakatani J, Takumi T, van Eede MC, Kerr TM, Muller C, Blakely RD, Veenstra-VanderWeele J, Henkelman RM, Lerch JP. Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Mol Psychiatry. 2015 Feb; 20(1):118-25. PMID: 25199916.
      View in: PubMed
    38. Portmann T, Yang M, Mao R, Panagiotakos G, Ellegood J, Dolen G, Bader PL, Grueter BA, Goold C, Fisher E, Clifford K, Rengarajan P, Kalikhman D, Loureiro D, Saw NL, Zhengqui Z, Miller MA, Lerch JP, Henkelman M, Shamloo M, Malenka RC, Crawley JN, Dolmetsch RE. Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome. Cell Rep. 2014 May 22; 7(4):1077-1092. PMID: 24794428.
      View in: PubMed
    39. Brielmaier J, Senerth JM, Silverman JL, Matteson PG, Millonig JH, DiCicco-Bloom E, Crawley JN. Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. Genes Brain Behav. 2014 Mar; 13(3):286-298. PMID: 24730055.
      View in: PubMed
    40. Silverman JL, Crawley JN. The promising trajectory of autism therapeutics discovery. Drug Discov Today. 2014 Jul; 19(7):838-44. PMID: 24362109.
      View in: PubMed
    41. Silverman JL, Gastrell PT, Karras MN, Solomon M, Crawley JN. Cognitive abilities on transitive inference using a novel touchscreen technology for mice. Cereb Cortex. 2015 May; 25(5):1133-42. PMID: 24293564.
      View in: PubMed
    42. Yang M, Loureiro D, Kalikhman D, Crawley JN. Male mice emit distinct ultrasonic vocalizations when the female leaves the social interaction arena. Front Behav Neurosci. 2013; 7:159. PMID: 24312027.
      View in: PubMed
    43. Kerr TM, Muller CL, Miah M, Jetter CS, Pfeiffer R, Shah C, Baganz N, Anderson GM, Crawley JN, Sutcliffe JS, Blakely RD, Veenstra-Vanderweele J. Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Mol Autism. 2013 Oct 01; 4(1):35. PMID: 24083388.
      View in: PubMed
    44. Kas MJ, Glennon JC, Buitelaar J, Ey E, Biemans B, Crawley J, Ring RH, Lajonchere C, Esclassan F, Talpos J, Noldus LP, Burbach JP, Steckler T. Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives. Psychopharmacology (Berl). 2014 Mar; 231(6):1125-46. PMID: 24048469.
      View in: PubMed
    45. Jones-Davis DM, Yang M, Rider E, Osbun NC, da Gente GJ, Li J, Katz AM, Weber MD, Sen S, Crawley J, Sherr EH. Quantitative trait loci for interhemispheric commissure development and social behaviors in the BTBR T? tf/J mouse model of autism. PLoS One. 2013; 8(4):e61829. PMID: 23613947.
      View in: PubMed
    46. Babineau BA, Yang M, Berman RF, Crawley JN. Low home cage social behaviors in BTBR T+tf/J mice during juvenile development. Physiol Behav. 2013 Apr 10; 114-115:49-54. PMID: 23510981.
      View in: PubMed
    47. Ellegood J, Babineau BA, Henkelman RM, Lerch JP, Crawley JN. Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging. Neuroimage. 2013 Apr 15; 70:288-300. PMID: 23275046.
      View in: PubMed
    48. Katz DM, Berger-Sweeney JE, Eubanks JH, Justice MJ, Neul JL, Pozzo-Miller L, Blue ME, Christian D, Crawley JN, Giustetto M, Guy J, Howell CJ, Kron M, Nelson SB, Samaco RC, Schaevitz LR, St Hillaire-Clarke C, Young JL, Zoghbi HY, Mamounas LA. Preclinical research in Rett syndrome: setting the foundation for translational success. Dis Model Mech. 2012 Nov; 5(6):733-45. PMID: 23115203.
      View in: PubMed
    49. Ey E, Yang M, Katz AM, Woldeyohannes L, Silverman JL, Leblond CS, Faure P, Torquet N, Le Sourd AM, Bourgeron T, Crawley JN. Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes Brain Behav. 2012 Nov; 11(8):928-941. PMID: 22989184.
      View in: PubMed
    50. Crawley JN. Translational animal models of autism and neurodevelopmental disorders. Dialogues Clin Neurosci. 2012 Sep; 14(3):293-305. PMID: 23226954.
      View in: PubMed
    51. Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, Leech JM, Steinberg J, Crawley JN, Regehr WG, Sahin M. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature. 2012 Aug 30; 488(7413):647-51. PMID: 22763451.
      View in: PubMed
    52. Silverman JL, Babineau BA, Oliver CF, Karras MN, Crawley JN. Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism. Neuropharmacology. 2013 May; 68:210-22. PMID: 22968082.
      View in: PubMed
    53. Wöhr M, Silverman JL, Scattoni ML, Turner SM, Harris MJ, Saxena R, Crawley JN. Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. Behav Brain Res. 2013 Aug 15; 251:50-64. PMID: 22820233.
      View in: PubMed
    54. Brielmaier J, Matteson PG, Silverman JL, Senerth JM, Kelly S, Genestine M, Millonig JH, DiCicco-Bloom E, Crawley JN. Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS One. 2012; 7(7):e40914. PMID: 22829897.
      View in: PubMed
    55. Silverman JL, Oliver CF, Karras MN, Gastrell PT, Crawley JN. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology. 2013 Jan; 64:268-82. PMID: 22801296.
      View in: PubMed
    56. Yang M, Bozdagi O, Scattoni ML, Wöhr M, Roullet FI, Katz AM, Abrams DN, Kalikhman D, Simon H, Woldeyohannes L, Zhang JY, Harris MJ, Saxena R, Silverman JL, Buxbaum JD, Crawley JN. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci. 2012 May 09; 32(19):6525-41. PMID: 22573675.
      View in: PubMed
    57. Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med. 2012 Apr 25; 4(131):131ra51. PMID: 22539775.
      View in: PubMed
    58. Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, McMahon DG, Ramamoorthy S, Daws LC, Sutcliffe JS, Blakely RD. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A. 2012 Apr 03; 109(14):5469-74. PMID: 22431635.
      View in: PubMed
    59. Yang M, Abrams DN, Zhang JY, Weber MD, Katz AM, Clarke AM, Silverman JL, Crawley JN. Low sociability in BTBR T+tf/J mice is independent of partner strain. Physiol Behav. 2012 Dec 05; 107(5):649-62. PMID: 22245067.
      View in: PubMed
    60. Babineau BA, Yang M, Crawley JN. Mainstreaming mice. Neuropsychopharmacology. 2012 Jan; 37(1):300-1. PMID: 22157866.
      View in: PubMed
    61. Mogil JS, Sorge RE, LaCroix-Fralish ML, Smith SB, Fortin A, Sotocinal SG, Ritchie J, Austin JS, Schorscher-Petcu A, Melmed K, Czerminski J, Bittong RA, Mokris JB, Neubert JK, Campbell CM, Edwards RR, Campbell JN, Crawley JN, Lariviere WR, Wallace MR, Sternberg WF, Balaban CD, Belfer I, Fillingim RB. Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nat Neurosci. 2011 Oct 23; 14(12):1569-73. PMID: 22019732.
      View in: PubMed
    62. Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, Crawley JN. Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learn Mem. 2011 Aug; 18(8):534-44. PMID: 21791566.
      View in: PubMed
    63. Yang M, Silverman JL, Crawley JN. Automated three-chambered social approach task for mice. Curr Protoc Neurosci. 2011 Jul; Chapter 8:Unit 8.26. PMID: 21732314.
      View in: PubMed
    64. Wöhr M, Roullet FI, Hung AY, Sheng M, Crawley JN. Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One. 2011; 6(6):e20631. PMID: 21695253.
      View in: PubMed
    65. Scattoni ML, Ricceri L, Crawley JN. Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters. Genes Brain Behav. 2011 Feb; 10(1):44-56. PMID: 20618443.
      View in: PubMed
    66. Wöhr M, Roullet FI, Crawley JN. Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism. Genes Brain Behav. 2011 Feb; 10(1):35-43. PMID: 20345893.
      View in: PubMed
    67. Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AM, Veenstra-VanderWeele J. Absence of preference for social novelty and increased grooming in integrin ß3 knockout mice: initial studies and future directions. Autism Res. 2011 Feb; 4(1):57-67. PMID: 21254450.
      View in: PubMed
    68. Roullet FI, Crawley JN. Mouse models of autism: testing hypotheses about molecular mechanisms. Curr Top Behav Neurosci. 2011; 7:187-212. PMID: 21225409.
      View in: PubMed
    69. Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, Kajiwara Y, Yang M, Katz AM, Scattoni ML, Harris MJ, Saxena R, Silverman JL, Crawley JN, Zhou Q, Hof PR, Buxbaum JD. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism. 2010 Dec 17; 1(1):15. PMID: 21167025.
      View in: PubMed
    70. Papaleo F, Yang F, Garcia S, Chen J, Lu B, Crawley JN, Weinberger DR. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry. 2012 Jan; 17(1):85-98. PMID: 20956979.
      View in: PubMed
    71. Yang M, Perry K, Weber MD, Katz AM, Crawley JN. Social peers rescue autism-relevant sociability deficits in adolescent mice. Autism Res. 2011 Feb; 4(1):17-27. PMID: 20928844.
      View in: PubMed
    72. Silverman JL, Yang M, Turner SM, Katz AM, Bell DB, Koenig JI, Crawley JN. Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience. 2010 Dec 29; 171(4):1197-208. PMID: 20888890.
      View in: PubMed
    73. Silverman JL, Turner SM, Barkan CL, Tolu SS, Saxena R, Hung AY, Sheng M, Crawley JN. Sociability and motor functions in Shank1 mutant mice. Brain Res. 2011 Mar 22; 1380:120-37. PMID: 20868654.
      View in: PubMed
    74. Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci. 2010 Jul; 11(7):490-502. PMID: 20559336.
      View in: PubMed
    75. Schorscher-Petcu A, Sotocinal S, Ciura S, Dupré A, Ritchie J, Sorge RE, Crawley JN, Hu SB, Nishimori K, Young LJ, Tribollet E, Quirion R, Mogil JS. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci. 2010 Jun 16; 30(24):8274-84. PMID: 20554879.
      View in: PubMed
    76. Roullet FI, Wöhr M, Crawley JN. Female urine-induced male mice ultrasonic vocalizations, but not scent-marking, is modulated by social experience. Behav Brain Res. 2011 Jan 01; 216(1):19-28. PMID: 20540967.
      View in: PubMed
    77. Llaneza DC, DeLuke SV, Batista M, Crawley JN, Christodulu KV, Frye CA. Communication, interventions, and scientific advances in autism: a commentary. Physiol Behav. 2010 Jun 01; 100(3):268-76. PMID: 20093134.
      View in: PubMed
    78. Crawley JN. Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease. Exp Suppl. 2010; 102:133-41. PMID: 21299066.
      View in: PubMed
    79. Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, Shaltiel G, Chen G, Crawley JN, Manji HK. The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry. 2010 May 01; 67(9):864-71. PMID: 20034613.
      View in: PubMed
    80. Silverman JL, Tolu SS, Barkan CL, Crawley JN. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology. 2010 Mar; 35(4):976-89. PMID: 20032969.
      View in: PubMed
    81. Ryan BC, Young NB, Crawley JN, Bodfish JW, Moy SS. Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Behav Brain Res. 2010 Mar 17; 208(1):178-88. PMID: 19941908.
      View in: PubMed
    82. Yang M, Crawley JN. Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci. 2009 Jul; Chapter 8:Unit 8.24. PMID: 19575474.
      View in: PubMed
    83. Kinney JW, Sanchez-Alavez M, Barr AM, Criado JR, Crawley JN, Behrens MM, Henriksen SJ, Bartfai T. Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylation. Neurobiol Learn Mem. 2009 Oct; 92(3):429-38. PMID: 19531380.
      View in: PubMed
    84. Yang M, Clarke AM, Crawley JN. Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability. Eur J Neurosci. 2009 Apr; 29(8):1663-77. PMID: 19419429.
      View in: PubMed
    85. Chadman KK, Yang M, Crawley JN. Criteria for validating mouse models of psychiatric diseases. Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 05; 150B(1):1-11. PMID: 18484083.
      View in: PubMed
    86. Yang M, Weber MD, Crawley JN. Light phase testing of social behaviors: not a problem. Front Neurosci. 2008 Dec; 2(2):186-91. PMID: 19225591.
      View in: PubMed
    87. Moy SS, Nadler JJ, Young NB, Nonneman RJ, Grossman AW, Murphy DL, D'Ercole AJ, Crawley JN, Magnuson TR, Lauder JM. Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav. 2009 Mar; 8(2):129-42. PMID: 19016890.
      View in: PubMed
    88. Scattoni ML, Gandhy SU, Ricceri L, Crawley JN. Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism. PLoS One. 2008 Aug 27; 3(8):e3067. PMID: 18728777.
      View in: PubMed
    89. Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, Weinberger DR, Chen J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci. 2008 Aug 27; 28(35):8709-23. PMID: 18753372.
      View in: PubMed
    90. Scattoni ML, Crawley J, Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev. 2009 Apr; 33(4):508-15. PMID: 18771687.
      View in: PubMed
    91. Ryan BC, Young NB, Moy SS, Crawley JN. Olfactory cues are sufficient to elicit social approach behaviors but not social transmission of food preference in C57BL/6J mice. Behav Brain Res. 2008 Nov 21; 193(2):235-42. PMID: 18586054.
      View in: PubMed
    92. Crawley JN. Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease. Cell Mol Life Sci. 2008 Jun; 65(12):1836-41. PMID: 18500642.
      View in: PubMed
    93. Chadman KK, Gong S, Scattoni ML, Boltuck SE, Gandhy SU, Heintz N, Crawley JN. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 2008 Jun; 1(3):147-58. PMID: 19360662.
      View in: PubMed
    94. Crawley JN. Behavioral phenotyping strategies for mutant mice. Neuron. 2008 Mar 27; 57(6):809-18. PMID: 18367082.
      View in: PubMed
    95. Moy SS, Nadler JJ, Young NB, Nonneman RJ, Segall SK, Andrade GM, Crawley JN, Magnuson TR. Social approach and repetitive behavior in eleven inbred mouse strains. Behav Brain Res. 2008 Aug 05; 191(1):118-29. PMID: 18440079.
      View in: PubMed
    96. Bainbridge NK, Koselke LR, Jeon J, Bailey KR, Wess J, Crawley JN, Wrenn CC. Learning and memory impairments in a congenic C57BL/6 strain of mice that lacks the M2 muscarinic acetylcholine receptor subtype. Behav Brain Res. 2008 Jun 26; 190(1):50-8. PMID: 18346798.
      View in: PubMed
    97. Stack CM, Lim MA, Cuasay K, Stone MM, Seibert KM, Spivak-Pohis I, Crawley JN, Waschek JA, Hill JM. Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Exp Neurol. 2008 May; 211(1):67-84. PMID: 18316078.
      View in: PubMed
    98. Chandran JS, Lin X, Zapata A, Höke A, Shimoji M, Moore SO, Galloway MP, Laird FM, Wong PC, Price DL, Bailey KR, Crawley JN, Shippenberg T, Cai H. Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiol Dis. 2008 Mar; 29(3):505-14. PMID: 18187333.
      View in: PubMed
    99. Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res. 2008 Mar 17; 188(1):178-94. PMID: 18068825.
      View in: PubMed
    100. Yang M, Scattoni ML, Zhodzishsky V, Chen T, Caldwell H, Young WS, McFarlane HG, Crawley JN. Social approach behaviors are similar on conventional versus reverse lighting cycles, and in replications across cohorts, in BTBR T+ tf/J, C57BL/6J, and vasopressin receptor 1B mutant mice. Front Behav Neurosci. 2007; 1:1. PMID: 18958184.
      View in: PubMed
    101. Scattoni ML, McFarlane HG, Zhodzishsky V, Caldwell HK, Young WS, Ricceri L, Crawley JN. Reduced ultrasonic vocalizations in vasopressin 1b knockout mice. Behav Brain Res. 2008 Mar 05; 187(2):371-8. PMID: 18005969.
      View in: PubMed
    102. Crawley JN. Medicine. Testing hypotheses about autism. Science. 2007 Oct 05; 318(5847):56-7. PMID: 17916718.
      View in: PubMed
    103. Crawley JN. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 2007 Oct; 17(4):448-59. PMID: 17919130.
      View in: PubMed
    104. Yang M, Zhodzishsky V, Crawley JN. Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. Int J Dev Neurosci. 2007 Dec; 25(8):515-21. PMID: 17980995.
      View in: PubMed
    105. Karlsson RM, Choe JS, Cameron HA, Thorsell A, Crawley JN, Holmes A, Heilig M. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl). 2008 Jan; 195(4):547-57. PMID: 17891380.
      View in: PubMed
    106. McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav. 2008 Mar; 7(2):152-63. PMID: 17559418.
      View in: PubMed
    107. Crawley JN, Chen T, Puri A, Washburn R, Sullivan TL, Hill JM, Young NB, Nadler JJ, Moy SS, Young LJ, Caldwell HK, Young WS. Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments. Neuropeptides. 2007 Jun; 41(3):145-63. PMID: 17420046.
      View in: PubMed
    108. Bailey KR, Pavlova MN, Rohde AD, Hohmann JG, Crawley JN. Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol Biochem Behav. 2007 Jan; 86(1):8-20. PMID: 17257664.
      View in: PubMed
    109. Ricceri L, Moles A, Crawley J. Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span. Behav Brain Res. 2007 Jan 10; 176(1):40-52. PMID: 16996147.
      View in: PubMed
    110. Nadler JJ, Zou F, Huang H, Moy SS, Lauder J, Crawley JN, Threadgill DW, Wright FA, Magnuson TR. Large-scale gene expression differences across brain regions and inbred strains correlate with a behavioral phenotype. Genetics. 2006 Nov; 174(3):1229-36. PMID: 16980393.
      View in: PubMed
    111. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res. 2007 Jan 10; 176(1):4-20. PMID: 16971002.
      View in: PubMed
    112. Tsai YS, Pendse A, Moy SS, Mohri I, Perez A, Crawley JN, Suzuki K, Maeda N. A de novo deafwaddler mutation of Pmca2 arising in ES cells and hitchhiking with a targeted modification of the Pparg gene. Mamm Genome. 2006 Jul; 17(7):716-22. PMID: 16845470.
      View in: PubMed
    113. DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, Schultz RT, Crawley J, Young LJ. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006 Jun 28; 26(26):6897-906. PMID: 16807320.
      View in: PubMed
    114. Wrenn CC, Turchi JN, Schlosser S, Dreiling JL, Stephenson DA, Crawley JN. Performance of galanin transgenic mice in the 5-choice serial reaction time attentional task. Pharmacol Biochem Behav. 2006 Mar; 83(3):428-40. PMID: 16626795.
      View in: PubMed
    115. Garcia-Fresco GP, Sousa AD, Pillai AM, Moy SS, Crawley JN, Tessarollo L, Dupree JL, Bhat MA. Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons. Proc Natl Acad Sci U S A. 2006 Mar 28; 103(13):5137-42. PMID: 16551741.
      View in: PubMed
    116. Moy SS, Nadler JJ, Magnuson TR, Crawley JN. Mouse models of autism spectrum disorders: the challenge for behavioral genetics. Am J Med Genet C Semin Med Genet. 2006 Feb 15; 142C(1):40-51. PMID: 16419099.
      View in: PubMed
    117. Bailey KR, Rustay NR, Crawley JN. Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. ILAR J. 2006; 47(2):124-31. PMID: 16547369.
      View in: PubMed
    118. Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005 Oct; 31(4):882-7. PMID: 16135561.
      View in: PubMed
    119. Rustay NR, Wrenn CC, Kinney JW, Holmes A, Bailey KR, Sullivan TL, Harris AP, Long KC, Saavedra MC, Starosta G, Innerfield CE, Yang RJ, Dreiling JL, Crawley JN. Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice. Neuropeptides. 2005 Jun; 39(3):239-43. PMID: 15944016.
      View in: PubMed
    120. Wiesenfeld-Hallin Z, Xu XJ, Crawley JN, Hökfelt T. Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models. Neuropeptides. 2005 Jun; 39(3):207-10. PMID: 15944013.
      View in: PubMed
    121. Karlsson RM, Holmes A, Heilig M, Crawley JN. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav. 2005 Mar; 80(3):427-36. PMID: 15740785.
      View in: PubMed
    122. He B, Counts SE, Perez SE, Hohmann JG, Koprich JB, Lipton JW, Steiner RA, Crawley JN, Mufson EJ. Ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice. Neuroscience. 2005; 133(2):371-80. PMID: 15885921.
      View in: PubMed
    123. Hygge-Blakeman K, Brumovsky P, Hao JX, Xu XJ, Hökfelt T, Crawley JN, Wiesenfeld-Hallin Z. Galanin over-expression decreases the development of neuropathic pain-like behaviors in mice after partial sciatic nerve injury. Brain Res. 2004 Oct 29; 1025(1-2):152-8. PMID: 15464755.
      View in: PubMed
    124. Laplante F, Crawley JN, Quirion R. Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice. Regul Pept. 2004 Oct 15; 122(2):91-8. PMID: 15380926.
      View in: PubMed
    125. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004 Oct; 3(5):287-302. PMID: 15344922.
      View in: PubMed
    126. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav. 2004 Oct; 3(5):303-14. PMID: 15344923.
      View in: PubMed
    127. Holmes A, Li Q, Koenig EA, Gold E, Stephenson D, Yang RJ, Dreiling J, Sullivan T, Crawley JN. Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior. Psychopharmacology (Berl). 2005 Mar; 178(2-3):276-85. PMID: 15365683.
      View in: PubMed
    128. Wrenn CC, Kinney JW, Marriott LK, Holmes A, Harris AP, Saavedra MC, Starosta G, Innerfield CE, Jacoby AS, Shine J, Iismaa TP, Wenk GL, Crawley JN. Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. Eur J Neurosci. 2004 Mar; 19(5):1384-96. PMID: 15016096.
      View in: PubMed
    129. Crawley JN. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev. 2004; 10(4):248-58. PMID: 15666335.
      View in: PubMed
    130. Yoshitake T, Wang FH, Kuteeva E, Holmberg K, Yamaguchi M, Crawley JN, Steiner R, Bartfai T, Ogren SO, Hökfelt T, Kehr J. Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test. Proc Natl Acad Sci U S A. 2004 Jan 06; 101(1):354-9. PMID: 14701907.
      View in: PubMed
    131. Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2003 Dec; 2(6):365-80. PMID: 14653308.
      View in: PubMed
    132. Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology. 2003 Dec; 28(12):2077-88. PMID: 12968128.
      View in: PubMed
    133. Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry. 2003 Nov 15; 54(10):953-9. PMID: 14625137.
      View in: PubMed
    134. Grass S, Jacoby AS, Iismaa TP, Crawley JN, Xu XJ, Wiesenfeld-Hallin Z. Flexor reflex excitability in mice lacking galanin receptor galanin-R1. Neurosci Lett. 2003 Jul 24; 345(3):153-6. PMID: 12842279.
      View in: PubMed
    135. Kinney JW, Starosta G, Crawley JN. Central galanin administration blocks consolidation of spatial learning. Neurobiol Learn Mem. 2003 Jul; 80(1):42-54. PMID: 12737933.
      View in: PubMed
    136. Grass S, Crawley JN, Xu XJ, Wiesenfeld-Hallin Z. Reduced spinal cord sensitization to C-fibre stimulation in mice over-expressing galanin. Eur J Neurosci. 2003 May; 17(9):1829-32. PMID: 12752782.
      View in: PubMed
    137. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L, Vishwanath J, Saavedra MC, Innerfield CE, Jacoby AS, Shine J, Iismaa TP, Crawley JN. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology. 2003 Jun; 28(6):1031-44. PMID: 12700679.
      View in: PubMed
    138. Crawley JN. Behavioral phenotyping of rodents. Comp Med. 2003 Apr; 53(2):140-6. PMID: 12784847.
      View in: PubMed
    139. Wrenn CC, Harris AP, Saavedra MC, Crawley JN. Social transmission of food preference in mice: methodology and application to galanin-overexpressing transgenic mice. Behav Neurosci. 2003 Feb; 117(1):21-31. PMID: 12619904.
      View in: PubMed
    140. Blakeman KH, Hao JX, Xu XJ, Jacoby AS, Shine J, Crawley JN, Iismaa T, Wiesenfeld-Hallin Z. Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors. Neuroscience. 2003; 117(1):221-7. PMID: 12605908.
      View in: PubMed
    141. Holmes A, Yang RJ, Murphy DL, Crawley JN. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology. 2002 Dec; 27(6):914-23. PMID: 12464448.
      View in: PubMed
    142. Wrenn CC, Marriott LK, Kinney JW, Holmes A, Wenk GL, Crawley JN. Galanin peptide levels in hippocampus and cortex of galanin-overexpressing transgenic mice evaluated for cognitive performance. Neuropeptides. 2002 Dec; 36(6):413-26. PMID: 12507436.
      View in: PubMed
    143. Counts SE, McGuire SO, Sortwell CE, Crawley JN, Collier TJ, Mufson EJ. Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons. J Neurochem. 2002 Oct; 83(2):442-51. PMID: 12423254.
      View in: PubMed
    144. Kinney JW, Starosta G, Holmes A, Wrenn CC, Yang RJ, Harris AP, Long KC, Crawley JN. Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn Mem. 2002 Jul-Aug; 9(4):178-90. PMID: 12177231.
      View in: PubMed
    145. Crawley JN, Mufson EJ, Hohmann JG, Teklemichael D, Steiner RA, Holmberg K, Xu ZQ, Blakeman KH, Xu XJ, Wiesenfeld-Hallin Z, Bartfai T, Hökfelt T. Galanin overexpressing transgenic mice. Neuropeptides. 2002 Apr-Jun; 36(2-3):145-56. PMID: 12359505.
      View in: PubMed
    146. Gold LH, Crawley JN. Introduction: transgenics and knockouts with mutations in genes for neuropeptides and their receptors. Neuropeptides. 2002 Apr-Jun; 36(2-3):61. PMID: 12398063.
      View in: PubMed
    147. Holmes A, Murphy DL, Crawley JN. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl). 2002 May; 161(2):160-7. PMID: 11981596.
      View in: PubMed
    148. Holmes A, Yang RJ, Crawley JN. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice. J Mol Neurosci. 2002 Feb-Apr; 18(1-2):151-65. PMID: 11931346.
      View in: PubMed
    149. Holmes A, Wrenn CC, Harris AP, Thayer KE, Crawley JN. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav. 2002 Jan; 1(1):55-69. PMID: 12886950.
      View in: PubMed
    150. McDonald MP, Miller KM, Li C, Deng C, Crawley JN. Motor deficits in fibroblast growth factor receptor-3 null mutant mice. Behav Pharmacol. 2001 Nov; 12(6-7):477-86. PMID: 11742142.
      View in: PubMed
    151. Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR, Crawley JN. Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci. 2001 Oct; 115(5):1129-44. PMID: 11584926.
      View in: PubMed
    152. Paylor R, Zhao Y, Libbey M, Westphal H, Crawley JN. Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiol Behav. 2001 Aug; 73(5):781-92. PMID: 11566211.
      View in: PubMed
    153. Steiner RA, Hohmann JG, Holmes A, Wrenn CC, Cadd G, Juréus A, Clifton DK, Luo M, Gutshall M, Ma SY, Mufson EJ, Crawley JN. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc Natl Acad Sci U S A. 2001 Mar 27; 98(7):4184-9. PMID: 11259657.
      View in: PubMed
    154. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 2001 Mar 08; 410(6825):207-12. PMID: 11242080.
      View in: PubMed
    155. Miyakawa T, Yared E, Pak JH, Huang FL, Huang KP, Crawley JN. Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components. Hippocampus. 2001; 11(6):763-75. PMID: 11811671.
      View in: PubMed
    156. Wrenn CC, Crawley JN. Pharmacological evidence supporting a role for galanin in cognition and affect. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Jan; 25(1):283-99. PMID: 11263757.
      View in: PubMed
    157. Counts SE, Perez SE, Kahl U, Bartfai T, Bowser RP, Deecher DC, Mash DC, Crawley JN, Mufson EJ. Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. CNS Drug Rev. 2001; 7(4):445-70. PMID: 11830760.
      View in: PubMed
    158. Kawai H, Allende ML, Wada R, Kono M, Sango K, Deng C, Miyakawa T, Crawley JN, Werth N, Bierfreund U, Sandhoff K, Proia RL. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem. 2001 Mar 09; 276(10):6885-8. PMID: 11133999.
      View in: PubMed
    159. Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev. 1999 Dec; 51(4):745-81. PMID: 10581329.
      View in: PubMed
    160. Crawley JN. The role of galanin in feeding behavior. Neuropeptides. 1999 Oct; 33(5):369-75. PMID: 10657514.
      View in: PubMed
    161. Paylor R, Hirotsune S, Gambello MJ, Yuva-Paylor L, Crawley JN, Wynshaw-Boris A. Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn Mem. 1999 Sep-Oct; 6(5):521-37. PMID: 10541472.
      View in: PubMed
    162. Gleason TC, Dreiling JL, Crawley JN. Rat strain differences in response to galanin on the Morris water task. Neuropeptides. 1999 Aug; 33(4):265-70. PMID: 10657502.
      View in: PubMed
    163. Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 1999 Jul 17; 835(1):18-26. PMID: 10448192.
      View in: PubMed
    164. Davis JA, Paylor R, McDonald MP, Libbey M, Ligler A, Bryant K, Crawley JN. Behavioral effects of ivermectin in mice. Lab Anim Sci. 1999 Jun; 49(3):288-96. PMID: 10403444.
      View in: PubMed
    165. Liu Y, Wada R, Kawai H, Sango K, Deng C, Tai T, McDonald MP, Araujo K, Crawley JN, Bierfreund U, Sandhoff K, Suzuki K, Proia RL. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest. 1999 Feb; 103(4):497-505. PMID: 10021458.
      View in: PubMed
    166. McDonald MP, Gleason TC, Robinson JK, Crawley JN. Galanin inhibits performance on rodent memory tasks. Ann N Y Acad Sci. 1998 Dec 21; 863:305-22. PMID: 9928180.
      View in: PubMed
    167. Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, Tessarollo L, Crawley JN, Johnson PF. Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A. 1998 Sep 01; 95(18):10908-13. PMID: 9724803.
      View in: PubMed
    168. Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem. 1998 Sep-Oct; 5(4-5):302-16. PMID: 10454356.
      View in: PubMed
    169. McDonald MP, Wong R, Goldstein G, Weintraub B, Cheng SY, Crawley JN. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learn Mem. 1998 Sep-Oct; 5(4-5):289-301. PMID: 10454355.
      View in: PubMed
    170. Cheng CM, Joncas G, Reinhardt RR, Farrer R, Quarles R, Janssen J, McDonald MP, Crawley JN, Powell-Braxton L, Bondy CA. Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. J Neurosci. 1998 Aug 01; 18(15):5673-81. PMID: 9671658.
      View in: PubMed
    171. McDonald MP, Willard LB, Wenk GL, Crawley JN. Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. J Neurosci. 1998 Jul 01; 18(13):5078-85. PMID: 9634573.
      View in: PubMed
    172. Jänne PA, Suchy SF, Bernard D, MacDonald M, Crawley J, Grinberg A, Wynshaw-Boris A, Westphal H, Nussbaum RL. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J Clin Invest. 1998 May 15; 101(10):2042-53. PMID: 9593760.
      View in: PubMed
    173. Norflus F, Tifft CJ, McDonald MP, Goldstein G, Crawley JN, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J Clin Invest. 1998 May 01; 101(9):1881-8. PMID: 9576752.
      View in: PubMed
    174. McDonald MP, Crawley JN. Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease. J Psychiatry Neurosci. 1997 Nov; 22(5):303-17. PMID: 9401311.
      View in: PubMed
    175. Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell. 1997 Sep 05; 90(5):895-905. PMID: 9298901.
      View in: PubMed
    176. Liu Y, Hoffmann A, Grinberg A, Westphal H, McDonald MP, Miller KM, Crawley JN, Sandhoff K, Suzuki K, Proia RL. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proc Natl Acad Sci U S A. 1997 Jul 22; 94(15):8138-43. PMID: 9223328.
      View in: PubMed
    177. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl). 1997 Jul; 132(2):107-24. PMID: 9266608.
      View in: PubMed
    178. Paylor R, Crawley JN. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl). 1997 Jul; 132(2):169-80. PMID: 9266614.
      View in: PubMed
    179. Crawley JN, Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav. 1997 Jun; 31(3):197-211. PMID: 9213134.
      View in: PubMed
    180. McDonald MP, Wenk GL, Crawley JN. Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin. Behav Neurosci. 1997 Jun; 111(3):552-63. PMID: 9189270.
      View in: PubMed
    181. De Bartolomeis A, Koprivica V, Pickar D, Crawley JN, Abbott LC. Opioidergic and dopaminergic gene expression in the caudate-putamen and accumbens of the mutant mouse, tottering (tg/tg). Brain Res Mol Brain Res. 1997 Jun; 46(1-2):321-4. PMID: 9191109.
      View in: PubMed
    182. Gershenfeld HK, Neumann PE, Mathis C, Crawley JN, Li X, Paul SM. Mapping quantitative trait loci for open-field behavior in mice. Behav Genet. 1997 May; 27(3):201-10. PMID: 9210791.
      View in: PubMed
    183. Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet. 1996 Nov; 14(3):348-52. PMID: 8896570.
      View in: PubMed
    184. König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature. 1996 Oct 10; 383(6600):535-8. PMID: 8849726.
      View in: PubMed
    185. McDonald MP, Crawley JN. Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed-nonmatching-to-position task. Behav Neurosci. 1996 Oct; 110(5):1025-32. PMID: 8919005.
      View in: PubMed
    186. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 1996 Jul 12; 86(1):159-71. PMID: 8689683.
      View in: PubMed
    187. Sills TL, Crawley JN. Individual differences in sugar consumption predict amphetamine-induced dopamine overflow in nucleus accumbens. Eur J Pharmacol. 1996 May 15; 303(3):177-81. PMID: 8813564.
      View in: PubMed
    188. Crawley JN. Unusual behavioral phenotypes of inbred mouse strains. Trends Neurosci. 1996 May; 19(5):181-2; discussion 188-9. PMID: 8723201.
      View in: PubMed
    189. Robinson JK, Zocchi A, Pert A, Crawley JN. Galanin microinjected into the medial septum inhibits scopolamine-induced acetylcholine overflow in the rat ventral hippocampus. Brain Res. 1996 Feb 12; 709(1):81-7. PMID: 8869559.
      View in: PubMed
    190. Holmes PV, Crawley JN. Olfactory bulbectomy increases prepro-galanin mRNA levels in the rat locus coeruleus. Brain Res Mol Brain Res. 1996 Feb; 36(1):184-8. PMID: 9011757.
      View in: PubMed
    191. Crawley JN. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sci. 1996; 58(24):2185-99. PMID: 8649205.
      View in: PubMed
    192. Mathis C, Neumann PE, Gershenfeld H, Paul SM, Crawley JN. Genetic analysis of anxiety-related behaviors and responses to benzodiazepine-related drugs in AXB and BXA recombinant inbred mouse strains. Behav Genet. 1995 Nov; 25(6):557-68. PMID: 8540894.
      View in: PubMed
    193. Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet. 1995 Oct; 11(2):170-6. PMID: 7550345.
      View in: PubMed
    194. Crawley JN. Biological actions of galanin. Regul Pept. 1995 Sep 22; 59(1):1-16. PMID: 12506409.
      View in: PubMed
    195. Corwin RL, Rowe PM, Crawley JN. Galanin and the galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. Am J Physiol. 1995 Sep; 269(3 Pt 2):R511-8. PMID: 7573550.
      View in: PubMed
    196. Corwin RL, Jörn A, Hardy M, Crawley JN. The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism. J Neurochem. 1995 Jul; 65(1):208-17. PMID: 7790862.
      View in: PubMed
    197. Holmes PV, Blanchard DC, Blanchard RJ, Brady LS, Crawley JN. Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacol Biochem Behav. 1995 Apr; 50(4):655-60. PMID: 7542391.
      View in: PubMed
    198. Holmes PV, de Bartolomeis A, Koprivica V, Crawley JN. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus. Synapse. 1995 Mar; 19(3):197-205. PMID: 7540319.
      View in: PubMed
    199. Yamanaka S, Johnson MD, Grinberg A, Westphal H, Crawley JN, Taniike M, Suzuki K, Proia RL. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc Natl Acad Sci U S A. 1994 Oct 11; 91(21):9975-9. PMID: 7937929.
      View in: PubMed
    200. Mathis C, Paul SM, Crawley JN. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology (Berl). 1994 Oct; 116(2):201-6. PMID: 7862949.
      View in: PubMed
    201. Robinson JK, Crawley JN. Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats. Behav Neurosci. 1994 Oct; 108(5):941-50. PMID: 7530011.
      View in: PubMed
    202. Abbott LC, Conforti ML, Isaacs KR, Crawley JN, Sterchi D. A simplified technique for histologic analysis of central nervous system tissues using glycol-methacrylate plastic coupled with pre-embedding immunocytochemistry. J Neurosci Methods. 1994 Sep; 54(1):23-9. PMID: 7529349.
      View in: PubMed
    203. Crawley JN. Cholecystokinin modulates dopamine-mediated behaviors. Differential actions in medial posterior versus anterior nucleus accumbens. Ann N Y Acad Sci. 1994 Mar 23; 713:138-42. PMID: 8185154.
      View in: PubMed
    204. Mathis C, Paul SM, Crawley JN. Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav Genet. 1994 Mar; 24(2):171-80. PMID: 8024534.
      View in: PubMed
    205. de Bartolomeis A, Austin MC, Goodwin GA, Spear LP, Pickar D, Crawley JN. Dopaminergic and peptidergic mRNA levels in juvenile rat brain after prenatal cocaine treatment. Brain Res Mol Brain Res. 1994 Feb; 21(3-4):321-32. PMID: 7909578.
      View in: PubMed
    206. Holmes PV, Koprivica V, Chough E, Crawley JN. Intraventricular administration of galanin does not affect behaviors associated with locus coeruleus activation in rats. Peptides. 1994; 15(7):1303-8. PMID: 7531843.
      View in: PubMed
    207. Crawley JN, Corwin RL. Biological actions of cholecystokinin. Peptides. 1994; 15(4):731-55. PMID: 7937354.
      View in: PubMed
    208. Drugan RC, Paul SM, Crawley JN. Decreased forebrain [35S]TBPS binding and increased [3H]muscimol binding in rats that do not develop stress-induced behavioral depression. Brain Res. 1993 Dec 24; 631(2):270-6. PMID: 8131055.
      View in: PubMed
    209. Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav. 1993 Dec; 46(4):967-72. PMID: 7906042.
      View in: PubMed
    210. Bartfai T, Langel U, Bedecs K, Andell S, Land T, Gregersen S, Ahrén B, Girotti P, Consolo S, Corwin R. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci U S A. 1993 Dec 01; 90(23):11287-91. PMID: 7504301.
      View in: PubMed
    211. Robinson JK, Crawley JN. Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample. J Neurosci. 1993 Dec; 13(12):5119-25. PMID: 7504722.
      View in: PubMed
    212. Crawley JN. Functional interactions of galanin and acetylcholine: relevance to memory and Alzheimer's disease. Behav Brain Res. 1993 Nov 30; 57(2):133-41. PMID: 7509609.
      View in: PubMed
    213. Corwin RL, Robinson JK, Crawley JN. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci. 1993 Nov 01; 5(11):1528-33. PMID: 7506975.
      View in: PubMed
    214. Robinson JK, Crawley JN. Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats. Behav Neurosci. 1993 Jun; 107(3):458-67. PMID: 7687133.
      View in: PubMed
    215. Crawley JN, Robinson JK, Langel U, Bartfai T. Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res. 1993 Jan 15; 600(2):268-72. PMID: 7679604.
      View in: PubMed
    216. Robinson JK, Crawley JN. The role of galanin in cholinergically-mediated memory processes. Prog Neuropsychopharmacol Biol Psychiatry. 1993 Jan; 17(1):71-85. PMID: 7677976.
      View in: PubMed
    217. Austin MC, Schultzberg M, Abbott LC, Montpied P, Evers JR, Paul SM, Crawley JN. Expression of tyrosine hydroxylase in cerebellar Purkinje neurons of the mutant tottering and leaner mouse. Brain Res Mol Brain Res. 1992 Oct; 15(3-4):227-40. PMID: 1279353.
      View in: PubMed
    218. Crawley JN. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. J Neurosci. 1992 Sep; 12(9):3380-91. PMID: 1527584.
      View in: PubMed
    219. Crawley JN, Evers JR, Paul SM. Polyamines inhibit N-methyl-D-aspartate antagonist-induced darting behavior in the rat prefrontal cortex. Brain Res. 1992 Jul 17; 586(1):6-11. PMID: 1511351.
      View in: PubMed
    220. Givens BS, Olton DS, Crawley JN. Galanin in the medial septal area impairs working memory. Brain Res. 1992 Jun 05; 582(1):71-7. PMID: 1379875.
      View in: PubMed
    221. Leppin C, Finiels-Marlier F, Crawley JN, Montpied P, Paul SM. Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo. Brain Res. 1992 May 22; 581(1):168-70. PMID: 1379868.
      View in: PubMed
    222. Schultzberg M, Austin MC, Crawley JN, Paul SM. Repeated administration of desmethylimipramine blocks the reserpine-induced increase in tyrosine hydroxylase mRNA in locus coeruleus neurons of the rat. Brain Res Mol Brain Res. 1991 Jul; 10(4):307-14. PMID: 1717808.
      View in: PubMed
    223. Crawley JN, Fiske SM, Durieux C, Derrien M, Roques BP. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. J Pharmacol Exp Ther. 1991 Jun; 257(3):1076-80. PMID: 2046021.
      View in: PubMed
    224. Crawley JN. Cholecystokinin-dopamine interactions. Trends Pharmacol Sci. 1991 Jun; 12(6):232-6. PMID: 2048219.
      View in: PubMed
    225. Jaskiw GE, Weinberger DR, Crawley JN. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biol Psychiatry. 1991 Apr 01; 29(7):703-6. PMID: 1711381.
      View in: PubMed
    226. Crawley JN, Austin MC, Fiske SM, Martin B, Consolo S, Berthold M, Langel U, Fisone G, Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J Neurosci. 1990 Nov; 10(11):3695-700. PMID: 1700084.
      View in: PubMed
    227. Laitinen K, Crawley JN, Mefford IN, De Witte P. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Brain Res. 1990 Jul 23; 523(2):342-6. PMID: 1698106.
      View in: PubMed
    228. Cottingham SL, Pickar D, Shimotake TK, Montpied P, Paul SM, Crawley JN. Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration. Cell Mol Neurobiol. 1990 Mar; 10(1):41-50. PMID: 1970757.
      View in: PubMed
    229. De Mesquita S, Beinfeld MC, Crawley JN. Microdialysis as an approach to quantitate the release of neuropeptides. Prog Neuropsychopharmacol Biol Psychiatry. 1990; 14 Suppl:S5-15. PMID: 2097673.
      View in: PubMed
    230. Crawley JN. Microdialysis. Introduction. Prog Neuropsychopharmacol Biol Psychiatry. 1990; 14 Suppl:S1-4. PMID: 1982971.
      View in: PubMed
    231. Crawley JN. Coexistence of neuropeptides and "classical" neurotransmitters. Functional interactions between galanin and acetylcholine. Ann N Y Acad Sci. 1990; 579:233-45. PMID: 1692455.
      View in: PubMed
    232. Austin MC, Cottingham SL, Paul SM, Crawley JN. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration. Synapse. 1990; 6(4):351-7. PMID: 1705056.
      View in: PubMed
    233. Consolo S, Palazzi E, Bertorelli R, Fisone G, Crawley J, Hökfelt T, Bartfai T. Functional aspects of acetylcholine-galanin coexistence in the brain. Prog Brain Res. 1990; 84:279-87. PMID: 1702545.
      View in: PubMed
    234. Dauge V, Bohme GA, Crawley JN, Durieux C, Stutzmann JM, Feger J, Blanchard JC, Roques BP. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264. Synapse. 1990; 6(1):73-80. PMID: 2399491.
      View in: PubMed
    235. Fisone G, Berthold M, Bedecs K, Undén A, Bartfai T, Bertorelli R, Consolo S, Crawley J, Martin B, Nilsson S. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proc Natl Acad Sci U S A. 1989 Dec; 86(23):9588-91. PMID: 2594786.
      View in: PubMed
    236. Crawley JN, Wenk GL. Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends Neurosci. 1989 Aug; 12(8):278-82. PMID: 2475942.
      View in: PubMed
    237. Drugan RC, Skolnick P, Paul SM, Crawley JN. A pretest procedure reliably predicts performance in two animal models of inescapable stress. Pharmacol Biochem Behav. 1989 Jul; 33(3):649-54. PMID: 2587607.
      View in: PubMed
    238. Drugan RC, Morrow AL, Weizman R, Weizman A, Deutsch SI, Crawley JN, Paul SM. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res. 1989 May 15; 487(1):45-51. PMID: 2546650.
      View in: PubMed
    239. Crawley JN. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion. Synapse. 1989; 3(4):346-55. PMID: 2740993.
      View in: PubMed
    240. Zohar J, Murphy DL, Crawley JN. Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1989; 13(5):775-9. PMID: 2675195.
      View in: PubMed
    241. Mefford IN, Lawrenz AL, Hsiao JK, Crawley JN. Activation in young rats induced by LY134046, an inhibitor of phenylethanolamine N-methyltransferase. Psychopharmacology (Berl). 1989; 98(2):240-4. PMID: 2502794.
      View in: PubMed
    242. Mastropaolo J, Nadi NS, Ostrowski NL, Crawley JN. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc Natl Acad Sci U S A. 1988 Dec; 85(24):9841-5. PMID: 2462255.
      View in: PubMed
    243. Crawley JN. Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens. Brain Res. 1988 Nov 15; 473(2):398-400. PMID: 3233498.
      View in: PubMed
    244. Glowa JR, Crawley J, Suzdak PD, Paul SM. Ethanol and the GABA receptor complex: studies with the partial inverse benzodiazepine receptor agonist Ro 15-4513. Pharmacol Biochem Behav. 1988 Nov; 31(3):767-72. PMID: 2855121.
      View in: PubMed
    245. Mastropaolo J, Crawley JN. Behavioral evidence for increased acetylcholine receptor sensitivity after nucleus basalis magnocellularis lesions in the rat. Eur J Pharmacol. 1988 Aug 24; 153(2-3):301-4. PMID: 3181290.
      View in: PubMed
    246. Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. Characterization of stress-induced alterations in [3H] Ro5-4864 binding to peripheral benzodiazepine receptors in rat heart and kidney. Pharmacol Biochem Behav. 1988 Aug; 30(4):1015-20. PMID: 2852369.
      View in: PubMed
    247. Suzdak PD, Paul SM, Crawley JN. Effects of Ro15-4513 and other benzodiazepine receptor inverse agonists on alcohol-induced intoxication in the rat. J Pharmacol Exp Ther. 1988 Jun; 245(3):880-6. PMID: 2455039.
      View in: PubMed
    248. Stivers JA, Skirboll LR, Long R, Crawley JN. Anatomical analysis of frontal cortex sites at which carbachol induces motor seizures in the rat. Pharmacol Biochem Behav. 1988 May; 30(1):129-36. PMID: 3174734.
      View in: PubMed
    249. Britton KT, Ehlers CL, Koob GF. Is ethanol antagonist Ro15-4513 selective for ethanol? Science. 1988 Feb 05; 239(4840):648-50. PMID: 3340849.
      View in: PubMed
    250. Khosla S, Crawley JN. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin. Life Sci. 1988; 42(2):153-9. PMID: 3336275.
      View in: PubMed
    251. Stivers JA, Kaltwasser MT, Hill PS, Hruby VJ, Crawley JN. Ventral tegmental oxytocin induces grooming. Peptides. 1988; 9 Suppl 1:223-31. PMID: 2856647.
      View in: PubMed
    252. Crawley JN. Modulation of mesolimbic dopaminergic behaviors by cholecystokinin. Ann N Y Acad Sci. 1988; 537:380-96. PMID: 3059933.
      View in: PubMed
    253. Merali Z, Merchant CA, Crawley JN, Coy DH, Heinz-Erian P, Jensen RT, Moody TW. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists. Synapse. 1988; 2(3):282-7. PMID: 2463692.
      View in: PubMed
    254. Stivers JA, Crawley JN. Substance P antagonists block carbachol-induced "boxing" behavior at a site of coexistence in the rat prefrontal cortex. Peptides. 1988; 9 Suppl 1:117-21. PMID: 2485249.
      View in: PubMed
    255. Moody TW, Merali Z, Crawley JN. The effects of anxiolytics and other agents on rat grooming behavior. Ann N Y Acad Sci. 1988; 525:281-90. PMID: 2455462.
      View in: PubMed
    256. Kaltwasser MT, Crawley JN. Oxytocin and cholecystokinin induce grooming behavior in the ventral tegmentum of the rat. Brain Res. 1987 Nov 17; 426(1):1-7. PMID: 3690307.
      View in: PubMed
    257. Angel I, Stivers JA, Paul SM, Crawley JN. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding. Pharmacol Biochem Behav. 1987 Jun; 27(2):291-7. PMID: 3628443.
      View in: PubMed
    258. Blumstein LK, Crawley JN, Davis LG, Baldino F. Neuropeptide modulation of apomorphine-induced stereotyped behavior. Brain Res. 1987 Feb 24; 404(1-2):293-300. PMID: 3567572.
      View in: PubMed
    259. Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. "Peripheral" benzodiazepine binding sites in the Maudsley reactive rat: selective decrease confined to peripheral tissues. Brain Res Bull. 1987 Jan; 18(1):143-5. PMID: 3030509.
      View in: PubMed
    260. Smith CB, Crawley JN. Anxiolytic action of CGS 9896 on mouse exploratory behavior. Eur J Pharmacol. 1986 Dec 16; 132(2-3):259-62. PMID: 2880734.
      View in: PubMed
    261. Suzdak PD, Glowa JR, Crawley JN, Schwartz RD, Skolnick P, Paul SM. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science. 1986 Dec 05; 234(4781):1243-7. PMID: 3022383.
      View in: PubMed
    262. Angel I, Kiss A, Stivers JA, Skirboll L, Crawley JN, Paul SM. Regulation of [3H]mazindol binding to subhypothalamic areas: involvement in glucoprivic feeding. Brain Res Bull. 1986 Dec; 17(6):873-7. PMID: 3801941.
      View in: PubMed
    263. Crawley JN, Glowa JR, Majewska MD, Paul SM. Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 1986 Nov 29; 398(2):382-5. PMID: 2879610.
      View in: PubMed
    264. Hommer DW, Stoner G, Crawley JN, Paul SM, Skirboll LR. Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype. J Neurosci. 1986 Oct; 6(10):3039-43. PMID: 3760947.
      View in: PubMed
    265. Bolger GT, Rafferty MF, Crawley JN, Paul SM, Skolnick P. Effects of calcium antagonists on phencyclidine behaviors. Pharmacol Biochem Behav. 1986 Jul; 25(1):45-9. PMID: 3749237.
      View in: PubMed
    266. Crawley JN, Stivers JA, Martin JV, Mendelson WB. Cholinergic induction of seizures in the rat prefrontal cortex. Life Sci. 1986 Jun 23; 38(25):2347-54. PMID: 3724361.
      View in: PubMed
    267. Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. Inescapable shock reduces [3H]Ro 5-4864 binding to "peripheral-type" benzodiazepine receptors in the rat. Pharmacol Biochem Behav. 1986 Jun; 24(6):1673-7. PMID: 3016760.
      View in: PubMed
    268. Wolkowitz O, Sutton M, Koulu M, Labarca R, Wilkinson L, Doran A, Hauger R, Pickar D, Crawley J. Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity. Eur J Pharmacol. 1986 Apr 02; 122(3):329-38. PMID: 3709658.
      View in: PubMed
    269. Crawley JN, Stivers JA, Hommer DW, Skirboll LR, Paul SM. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide. J Pharmacol Exp Ther. 1986 Feb; 236(2):320-30. PMID: 3003339.
      View in: PubMed
    270. Drugan RC, Skolnick P, Paul SM, Crawley JN. Low doses of muscimol produce anticonflict actions in the lateral septum of the rat. Neuropharmacology. 1986 Feb; 25(2):203-5. PMID: 3703171.
      View in: PubMed
    271. Skirboll LR, Crawley JN, Hommer DW. Functional studies of cholecystokinin-dopamine co-existence: electrophysiology and behavior. Prog Brain Res. 1986; 68:357-70. PMID: 3562851.
      View in: PubMed
    272. Crawley JN, Kiss JZ. Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin. Peptides. 1985 Sep-Oct; 6(5):927-35. PMID: 4080609.
      View in: PubMed
    273. Crawley JN, Olschowka JA, Diz DI, Jacobowitz DM. Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat. Peptides. 1985 Sep-Oct; 6(5):891-901. PMID: 2417203.
      View in: PubMed
    274. Crawley JN, Stivers JA, Blumstein LK, Paul SM. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence. J Neurosci. 1985 Aug; 5(8):1972-83. PMID: 4040554.
      View in: PubMed
    275. Drugan RC, Maier SF, Skolnick P, Paul SM, Crawley JN. An anxiogenic benzodiazepine receptor ligand induces learned helplessness. Eur J Pharmacol. 1985 Jul 31; 113(3):453-7. PMID: 2995072.
      View in: PubMed
    276. Crawley JN, Hommer DW, Skirboll LR. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat. Brain Res. 1985 Jun 03; 335(2):337-41. PMID: 4005562.
      View in: PubMed
    277. Hommer DW, Palkovits M, Crawley JN, Paul SM, Skirboll LR. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components. J Neurosci. 1985 Jun; 5(6):1387-92. PMID: 4009236.
      View in: PubMed
    278. Crawley JN, Sutton ME, Pickar D. Animal models of self-destructive behavior and suicide. Psychiatr Clin North Am. 1985 Jun; 8(2):299-310. PMID: 2410895.
      View in: PubMed
    279. Crawley JN. A monoamine oxidase inhibitor reverses the 'separation syndrome' in a new hamster separation model of depression. Eur J Pharmacol. 1985 May 28; 112(1):129-33. PMID: 4040468.
      View in: PubMed
    280. Crawley JN, Ninan PT, Pickar D, Chrousos GP, Linnoila M, Skolnick P, Paul SM. Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeys. J Neurosci. 1985 Feb; 5(2):477-85. PMID: 2983041.
      View in: PubMed
    281. Crawley JN. Cholecystokinin potentiates dopamine-mediated behaviors in the nucleus accumbens, a site of CCK-DA co-existence. Psychopharmacol Bull. 1985; 21(3):523-7. PMID: 4034868.
      View in: PubMed
    282. Crawley JN. Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides? Ann N Y Acad Sci. 1985; 448:1-8. PMID: 3861115.
      View in: PubMed
    283. Crawley JN. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens. Ann N Y Acad Sci. 1985; 448:283-92. PMID: 3861122.
      View in: PubMed
    284. Crawley JN. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev. 1985; 9(1):37-44. PMID: 2858080.
      View in: PubMed
    285. Crawley JN. Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide pools. Peptides. 1985; 6 Suppl 2:129-36. PMID: 3001671.
      View in: PubMed
    286. Crawley JN. Neurochemical investigation of the afferent pathway from the vagus nerve to the nucleus tractus solitarius in mediating the "satiety syndrome" induced by systemic cholecystokinin. Peptides. 1985; 6 Suppl 1:133-7. PMID: 4047976.
      View in: PubMed
    287. Hommer DW, Pickar D, Crawley JN, Weingartner H, Paul SM. The effects of cholecystokinin-like peptides in schizophrenics and normal human subjects. Ann N Y Acad Sci. 1985; 448:542-52. PMID: 3896099.
      View in: PubMed
    288. Crawley JN, Kiss JZ, Mezey E. Bilateral midbrain transections block the behavioral effects of cholecystokinin on feeding and exploration in rats. Brain Res. 1984 Nov 26; 322(2):316-21. PMID: 6509319.
      View in: PubMed
    289. Yachnis AT, Crawley JN, Jensen RT, McGrane MM, Moody TW. The antagonism of bombesin in the CNS by substance P analogues. Life Sci. 1984 Nov 05; 35(19):1963-9. PMID: 6208451.
      View in: PubMed
    290. Hirsch MD, O'Donohue TL, Wilson R, Sawyer TK, Hruby VJ, Hadley ME, Cody WL, Knittel JJ, Crawley JN. Structural and conformational modifications of alpha-MSH/ACTH4-10 provide melanotropin analogues with highly potent behavioral activities. Peptides. 1984 Nov-Dec; 5(6):1197-201. PMID: 6099564.
      View in: PubMed
    291. Squires RF, Saederup E, Crawley JN, Skolnick P, Paul SM. Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci. 1984 Oct 01; 35(14):1439-44. PMID: 6090836.
      View in: PubMed
    292. Crawley JN, St-Pierre S, Gaudreau P. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide. J Pharmacol Exp Ther. 1984 Aug; 230(2):438-44. PMID: 6086888.
      View in: PubMed
    293. Crawley JN, Skolnick P, Paul SM. Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse. Neuropharmacology. 1984 May; 23(5):531-7. PMID: 6146107.
      View in: PubMed
    294. Crawley JN, Schwaber JS. Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius. Brain Res. 1984 Mar 19; 295(2):289-99. PMID: 6713189.
      View in: PubMed
    295. Crawley JN, Blumstein LK, Baldino F. Anxiolytic-like properties of fominoben. Eur J Pharmacol. 1984 Jan 27; 97(3-4):277-81. PMID: 6142823.
      View in: PubMed
    296. Skolnick P, Ninan P, Insel T, Crawley J, Paul S. A novel chemically induced animal model of human anxiety. Psychopathology. 1984; 17 Suppl 1:25-36. PMID: 6143342.
      View in: PubMed
    297. Crawley JN. Preliminary report of a new rodent separation model of depression. Prog Neuropsychopharmacol Biol Psychiatry. 1984; 8(3):447-57. PMID: 6541359.
      View in: PubMed
    298. Crawley JN. Cholecystokinin accelerates the rate of habituation to a novel environment. Pharmacol Biochem Behav. 1984 Jan; 20(1):23-7. PMID: 6320229.
      View in: PubMed
    299. Crawley JN, Ninan PT, Pickar D, Chrousos GP, Skolnick P, Paul SM. Behavioral and physiological responses to benzodiazepine receptor antagonists. Psychopharmacol Bull. 1984; 20(3):403-7. PMID: 6147874.
      View in: PubMed
    300. Crawley JN. Evaluation of a proposed hamster separation model of depression. Psychiatry Res. 1984 Jan; 11(1):35-47. PMID: 6584930.
      View in: PubMed
    301. Skolnick P, Crawley JN, Glowa JR, Paul SM. beta-Carboline-induced anxiety states. Psychopathology. 1984; 17 Suppl 3:52-60. PMID: 6505120.
      View in: PubMed
    302. Crawley JN, Schwaber JS. Nucleus tractus solitarius lesions block the behavioral actions of cholecystokinin. Peptides. 1983 Sep-Oct; 4(5):743-7. PMID: 6318204.
      View in: PubMed
    303. Charlton CG, Miller RL, Crawley JN, Handelmann GE, O'Donohue TL. Secretin modulation of behavioral and physiological functions in the rat. Peptides. 1983 Sep-Oct; 4(5):739-42. PMID: 6657519.
      View in: PubMed
    304. Crawley JN. Divergent effects of cholecystokinin, bombesin, and lithium on rat exploratory behaviors. Peptides. 1983 Jul-Aug; 4(4):405-10. PMID: 6316290.
      View in: PubMed
    305. Crawley JN, Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature. 1983 Apr 21; 302(5910):703-6. PMID: 6300693.
      View in: PubMed
    306. Crawley JN, Patel J, Marangos PJ. Adenosine uptake inhibitors potentiate the sedative effects of adenosine. Neurosci Lett. 1983 Apr 11; 36(2):169-74. PMID: 6306520.
      View in: PubMed
    307. Skolnick P, Paul S, Crawley J, Lewin E, Lippa A, Clody D, Irmscher K, Saiko O, Minck KO. Antagonism of the anxiolytic action of diazepam and chlordiazepoxide by the novel imidazopyridines, EMD 39593 and EMD 41717. Eur J Pharmacol. 1983 Apr 08; 88(4):319-27. PMID: 6688050.
      View in: PubMed
    308. Crawley JN, Moody TW. Anxiolytics block excessive grooming behavior induced by ACTH1-24 and bombesin. Brain Res Bull. 1983 Mar; 10(3):399-401. PMID: 6303524.
      View in: PubMed
    309. Blumstein LK, Crawley JN. Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1983 Jan; 18(1):37-40. PMID: 6828535.
      View in: PubMed
    310. Rojas-Ramirez JA, Crawley JN, Mendelson WB. Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin. Neuropeptides. 1982 Dec; 3(2):129-38. PMID: 7162563.
      View in: PubMed
    311. Cain M, Weber RW, Guzman F, Cook JM, Barker SA, Rice KC, Crawley JN, Paul SM, Skolnick P. Beta-carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors. J Med Chem. 1982 Sep; 25(9):1081-91. PMID: 6127411.
      View in: PubMed
    312. Crawley JN, Davis LG. Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull. 1982 Jun; 8(6):609-12. PMID: 6890398.
      View in: PubMed
    313. Crawley JN, Rojas-Ramirez JA, Mendelson WB. The role of central and peripheral cholecystokinin in mediating appetitive behaviors. Peptides. 1982 May-Jun; 3(3):535-8. PMID: 6289285.
      View in: PubMed
    314. Moody TW, Crawley JN, Jensen RT. Pharmacology and neurochemistry of bombesin-like peptides. Peptides. 1982 May-Jun; 3(3):559-63. PMID: 6181494.
      View in: PubMed
    315. Crawley JN, Szara S, Pryor GT, Creveling CR, Bernard BK. Development and evaluation of a computer-automated color TV tracking system for automatic recording of the social and exploratory behavior of small animals. J Neurosci Methods. 1982 Mar; 5(3):235-47. PMID: 7078256.
      View in: PubMed
    316. Skolnick P, Williams EF, Cook JM, Cain M, Rice KC, Mendelson WB, Crawley JN, Paul SM. beta-Carbolines and benzodiazepine receptors: structure-activity relationships and pharmacologic activity. Prog Clin Biol Res. 1982; 90:233-52. PMID: 6287491.
      View in: PubMed
    317. Crawley JN, Marangos PJ, Stivers J, Goodwin FK. Chronic clonazepam administration induces benzodiazepine receptor subsensitivity. Neuropharmacology. 1982 Jan; 21(1):85-9. PMID: 6278355.
      View in: PubMed
    318. Marangos PJ, Crawley JN. Chronic benzodiazepine treatment increases [3H]muscimol binding in mouse brain. Neuropharmacology. 1982 Jan; 21(1):81-4. PMID: 6278354.
      View in: PubMed
    319. Crawley JN, Patel J, Marangos PJ. Behavioral characterization of two long-lasting adenosine analogs: sedative properties and interaction with diazepam. Life Sci. 1981 Dec 21; 29(25):2623-30. PMID: 7321779.
      View in: PubMed
    320. Crawley JN. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav. 1981 Nov; 15(5):695-9. PMID: 6118883.
      View in: PubMed
    321. Crawley JN, Hays SE, Paul SM, Goodwin FK. Cholecystokinin reduces exploratory behavior in mice. Physiol Behav. 1981 Sep; 27(3):407-11. PMID: 6278520.
      View in: PubMed
    322. Skolinick P, Paul S, Crawley J, Rice K, Barker S, Weber R, Cain M, Cook J. 3-hydroxymethyl-beta-carboline antagonizes some pharmacologic actions of diazepam. Eur J Pharmacol. 1981 Feb 19; 69(4):525-7. PMID: 6265233.
      View in: PubMed
    323. Crawley JN, Marangos PJ, Paul SM, Skolnick P, Goodwin FK. Interaction between purine and benzodiazepine: Inosine reverses diazepam-induced stimulation of mouse exploratory behavior. Science. 1981 Feb 13; 211(4483):725-7. PMID: 6256859.
      View in: PubMed
    324. Swann AC, Crawley JN, Grant SJ, Maas JW. Noradrenergic stimulation in vivo increases (Na+, K+)-adenosine triphosphatase activity. Life Sci. 1981 Jan 19; 28(3):251-6. PMID: 6261058.
      View in: PubMed
    325. Crawley JN, Hays SE, O'Donohue TL, Paul SM, Goodwin FK. Neuropeptide modulation of social and exploratory behaviors in laboratory rodents. Peptides. 1981; 2 Suppl 1:123-9. PMID: 7267400.
      View in: PubMed
    326. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980 Aug; 13(2):167-70. PMID: 6106204.
      View in: PubMed
    327. Crawley JN, Maas JW, Roth RH. Biochemical evidence for simultaneous activation of multiple locus coeruleus efferents. Life Sci. 1980 Apr 28; 26(17):1373-8. PMID: 6991843.
      View in: PubMed
    328. Crawley JN, Maas JW, Roth RH. Evidence against specificity of electrical stimulation of the nucleus locus coeruleus in activating the sympathetic nervous system in the rat. Brain Res. 1980 Feb 10; 183(2):301-11. PMID: 7353141.
      View in: PubMed
    329. Crawley JN, Laverty R, Roth RH. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal. Eur J Pharmacol. 1979 Aug 01; 57(2-3):247-50. PMID: 573692.
      View in: PubMed
    330. Crawley JN, Roth RH, Maas JW. Locus coeruleus stimulation increases noradrenergic metabolite levels in rat spinal cord. Brain Res. 1979 Apr 20; 166(1):180-4. PMID: 421150.
      View in: PubMed
    331. Crawley JN, Maas JW, Roth RH. Increase in plasma 3-methoxy-4-hydroxyphenethyleneglycol following stimulation of the nucleus locus coeruleus [proceedings]. Psychopharmacol Bull. 1979 Apr; 15(2):27-9. PMID: 107543.
      View in: PubMed
    332. Crawley JN, Hattox SE, Maas JW, Roth RH. 3-Methoxy-4-hydroxyphenethyleneglycol increase in plasma after stimulation of the nucleus locus coeruleus. Brain Res. 1978 Feb 10; 141(2):380-4. PMID: 626910.
      View in: PubMed
    333. Crawley JN, Contrera JF. Intraventricular 6-hydroxydopamine lowers isolation-induced fighting behavior in male mice. Pharmacol Biochem Behav. 1976 Apr; 4(4):381-4. PMID: 945581.
      View in: PubMed
    334. Crawley JN, Schleidt WM, Contrera JF. Does social environment decrease propensity to fight in male mice? Behav Biol. 1975 Sep; 15(1):73-83. PMID: 1237289.
      View in: PubMed